IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

McKinsey & Company is a global management consulting firm committed to helping organizations accelerate sustainable and inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.

Danaher’s Diagnostics companies are accelerating the real-life impact of precision diagnostics, enabling healthcare providers to diagnose diseases with unprecedented speed and precision.

The Danaher ecosystem — made up of more than 15 businesses with leadership positions in their respective end markets — is dedicated to advancing continuous improvement and accelerating innovation to make a meaningful impact. Each business is backed by Danaher and its resources, including the Danaher Business System, which empowers our businesses to make a tangible difference in lives around the world. We take on the most pressing challenges and leverage our expertise in science and technology to deliver transformative innovations.

Beckman Coulter Diagnostics is part of the Danaher family of companies and is working to shorten the path to Alzheimer’s Disease diagnosis by advancing blood-based biomarkers that may one day help identify neurodegenerative diseases earlier— before symptoms appear—so patients and families can plan and act sooner.

Reliant AI is an applied artificial intelligence company dedicated to empowering pharmaceutical organizations with data-driven decision intelligence solutions. Founded by cutting-edge machine learning researchers and life sciences experts, Reliant AI enables the life sciences ecosystem to make smarter, faster, and more reliable business decisions. The company specializes in scalable, applied AI solutions for use cases such as portfolio prioritization, literature reviews and epidemiological modeling—transforming complex data into actionable insights.

With a focus on transparency, ethics, and innovation, Reliant ensures that its technologies are both powerful and responsible. Its team of AI researchers, engineers, and data scientists work collaboratively with clients to design custom solutions that enhance efficiency and reduce the operational costs of drug development. Whether optimizing commercial assessments, forecasting, or monitoring gaps in scientific evidence in the literature, Reliant stands at the forefront of intelligent agentic automation.

For 25+ years, Signant Health has been pioneering solutions and methodologies that propel clinical research programs toward regulatory success. Our approach combines deep scientific expertise with comprehensive eClinical solutions, enabling study teams to capture reliable evidence while making trials more manageable for sites and more meaningful for patients.

From the smallest biotech running their first trial to global pharma sponsors and CROs launching pivotal, multinational studies, we're the partner who's been there before - supporting over 6,000 studies across 90+ countries, and contributing to 25% of recent FDA and EMA drug approvals.

Visit www.signanthealth.com to discover how we deliver Proof at the Speed of Life™

Suvoda is a global clinical trial technology company with a real-time experience platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.

Annovis Bio is a late-stage biotechnology company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The company’s lead drug candidate, buntanetap, has a distinctive mechanism of action: it inhibits the translation of multiple neurotoxic proteins involved in neurodegeneration, thereby improving neuronal communication, reducing inflammation, and restoring cellular health — ultimately leading to cognitive and functional benefits. Annovis is currently enrolling and treating patients in a pivotal Phase 3 study in early Alzheimer’s disease (AD), following encouraging Phase 2/3 results that demonstrated significant cognitive improvement in the same population, along with biomarker evidence of reduced neuroinflammation and neurodegeneration. Annovis Bio is dedicated to redefining the treatment of neurodegenerative disorders and delivering truly meaningful outcomes for patients.

Worldwide Clinical Trials (Worldwide) is a full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications. Worldwide’s capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by an accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program. Worldwide is therapeutically focused on neuroscience, oncology, rare disease, and cardiometabolic and inflammatory disease. Its global footprint spans over 60 countries with more than 3,500 team members.

QuantHealth is a pioneering AI-driven healthcare company transforming drug development through its advanced clinical trial simulations. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct loss to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success.

More information coming soon...

Accenture is a global professional services company helping businesses, governments, and organizations build digital cores, optimize operations, and accelerate growth. With 791,000 people in over 120 countries, we lead change through technology, cloud, data, and AI. Our services span Strategy & Consulting, Technology, Operations, Industry X, and Song. We deliver 360° value through innovation, deep industry expertise, and global delivery capabilities. Our culture of shared success and strong ecosystem partnerships enables trusted, lasting relationships. We measure success by the value we create for clients, communities, shareholders, and each other. Learn more at https://www.accenture.com.